Key takeaways
- • $149-299/mo compounded — 70-80% cheaper than brand cash list.
- • Not FDA-approved as finished product — compounded under 503A loophole, not full safety review.
- • March 2026 FDA enforcement targeting compounded GLP-1 telehealth — Henry not yet warned.
- • Established brand since 2022 — longer track record vs newer entrants.
- • No direct insurance handling — pure cash-pay model.
What Henry Meds is
Henry Meds is a telehealth platform launched 2022 specializing in compounded GLP-1 medications. Operates with licensed US providers + 503A-licensed compounding pharmacies. Cash-pay only — no insurance handling. Brand recognition in compounded category competitive with Eden, SkinnyRx, MEDVi.
Pricing breakdown
| Drug | Monthly |
|---|---|
| Compounded semaglutide — entry / starter | $149–199/mo |
| Compounded semaglutide — maintenance | $299/mo |
| Compounded tirzepatide — starter | $299/mo |
| Compounded tirzepatide — maintenance | $399/mo |
What Henry Meds does well
70-80% cheaper than brand cash list price
Established compounded brand since 2022
Async-first model — fast intake to Rx
Tirzepatide compounded option (less common vs semaglutide)
No insurance friction — pure cash-pay simplicity
Provider network in all 50 states
Where Henry falls short
Compounded = NOT FDA-approved as finished product
March 2026 FDA enforcement context applies
No insurance integration — full cash burden
Cancellation difficulty reported in Trustpilot
No labs included — bare-bones service
Limited customer service depth vs Hims/Ro
Who Henry is best for
Best fit: Cash-pay patients accepting FDA enforcement risk for 70-80% savings vs brand. Patients wanting established compounded brand with track record. Tirzepatide patients (compounded supply less common vs semaglutide).
Poor fit: Insurance-covered patients (Ro/Hers brand path cheaper net). Risk-averse patients. Patients wanting labs/coaching. Patients near major FDA enforcement zones.
Henry Meds vs. other GLP-1 providers — compare
SponsoredSee how Henry Meds stacks up against other telehealth GLP-1 providers, ranked by our editorial score. Visit a partner to check current pricing and eligibility — we compare and link, we never sell medication.
Advertising disclosure: we may earn a commission if you sign up through these links, at no extra cost to you — it never affects our rankings. How we make money
- Sesame Care· from $208/moTop ratedTelehealth · online visit
- SkinnyRx· from $199/moCompounded not offered in AL, LA, MS — check before startingTelehealth · online visitCompounded · not FDA-approved
- Enhance MD· price shown after their intakeNo lab work to startRestricted in AL, AR, GA, HI, LA, MS, MO, ND, SC, TN, WV — check before startingTelehealth · online visitCompounded · not FDA-approved
- HealthRX· from $165/moLowest starting priceon the 12-month plan, $1,188 billed upfrontTelehealth · online visitCompounded · not FDA-approved
FAQ
Is Henry Meds legit?
Henry Meds operates licensed US providers and works with licensed compounding pharmacies. Founded 2022, established brand in compounded GLP-1 category. Provider licensing + pharmacy licensing legitimate. The medications themselves (compounded semaglutide/tirzepatide) are NOT FDA-approved as finished products — that's the regulatory caveat.
What does Henry Meds cost?
Compounded semaglutide starts around $149/mo at the entry dose and runs to roughly $199/mo starter / $299/mo maintenance as you titrate. Tirzepatide options are a similar range. No separate telehealth fee — bundled with medication. Significantly cheaper than brand Wegovy/Zepbound cash list (~$1,349/mo), but carries FDA enforcement risk. Confirm current pricing on Henry Meds before purchasing.
Is compounded semaglutide safe?
Compounded semaglutide is pharmacy-mixed under section 503A — bypasses FDA finished-product safety/efficacy review. Active ingredient is same molecule. Risks: dose accuracy variance, injection site reactions, contamination if pharmacy QC weak. Henry uses 503A-licensed pharmacies, but FDA explicitly warns against compounded GLP-1 outside of acute drug shortage (which ended April 2025 for semaglutide, March 2025 tirzepatide).
Will FDA shut Henry down?
Unknown but possible. March 2026 FDA warning letters to 30+ telehealth firms re: compounded GLP-1 increased regulatory pressure. Henry has not received direct warning letter as of June 2026, but operates in the same enforcement crosshair. Acquiring Wegovy/Zepbound brand prescribing capacity (as Hers + Ro) would diversify risk.
How does Henry compare to Eden?
Both are compounded-only in a similar $149-299/mo range, and Eden has a cheaper $99/mo starter. But the third-party trust signals differ sharply: Henry Meds shows 4.5★ on Trustpilot, yet Trustpilot has flagged that profile for review manipulation and the BBB grades Henry F (100% non-response to consumer complaints). Eden shows 4.7★ with no fraud flag and a BBB B. On that record we do NOT recommend Henry Meds; if you are weighing the two, weight the BBB record and the Trustpilot fraud flag, not the star average.
What if I want to switch to brand later?
Easy — switch to Ro, Hers, or LifeMD after insurance verification. Stop Henry monthly billing first; new provider intake reviews your prior dose to maintain titration level. No medical interruption needed.
Bottom line
Henry Meds delivers compounded GLP-1 access at 70-80% brand savings — real cost win if you have not insurance coverage and accept FDA enforcement risk. Brand-name path (Ro/Hers) safer regulatory but much pricier without insurance. Full ranking.
Sources
Editorial only — not medical advice. Pricing accurate as of 2026-06-05; verify with Henry before deciding.